Literature DB >> 2473044

Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma.

K P Dieckmann1, W Düe, H W Bauer.   

Abstract

Serum beta-HCG was elevated in 10 of 83 consecutive patients with histologically pure seminoma (12%). Six patients with diagnostic stage I were successfully treated by radiation therapy. One patient with state IIc suffered a mediastinal relapse following retroperitoneal radiotherapy. Two other patients with high tumour burden achieved complete remission after induction chemotherapy followed by surgery and radiotherapy, respectively. One patient with retroperitoneal bulky disease reached permanent complete remission after radiation therapy alone. Beta-HCG-positive seminomas constitute a distinct category of germ-cell tumours on the basis of morphological and clinical features. Corresponding to the intermediate histological position between seminoma and nonseminoma, safe treatment of beta-HCG-positive seminoma can be achieved by radiotherapy in stage I, by retroperitoneal lymphadenectomy plus adjuvant chemotherapy in stages IIa, b and by induction chemotherapy in stages IIc and III.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473044     DOI: 10.1007/bf02550806

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  32 in total

1.  The significance of positive chorionic gonadotropins in apparently pure seminoma of the testis.

Authors:  P Mauch; R Weichselbaum; L Botnick
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-06       Impact factor: 7.038

2.  Elevated serum alphafetoprotein and seminoma: clinical evidence for a histologic continuum?

Authors:  D Raghavan; A L Sullivan; M J Peckham; A M Neville
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

3.  The differential diagnosis of testicular germ cell tumors in theory and practice. A critical analysis of two major systems of classifiction and review of 389 cases.

Authors:  A R von Hochstetter; C E Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982-08

4.  Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma.

Authors:  N E Skakkebaek; J G Berthelsen; A Giwercman; J Müller
Journal:  Int J Androl       Date:  1987-02

Review 5.  Testicular germ cell tumours. Current problems of histogenesis and classification.

Authors:  F Kiss; J Juhász
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

6.  [Clinical, endocrinological and pathohistologic aspects of beta-HCG positive seminoma].

Authors:  W Kuber; C Kratzik; M Susani
Journal:  Wien Klin Wochenschr       Date:  1984-09-14       Impact factor: 1.704

7.  Autopsy findings in 154 patients with germ cell tumors of the testis.

Authors:  J J Bredael; D Vugrin; W F Whitmore
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

8.  The management of metastatic seminoma testis.

Authors:  D Ball; A Barrett; M J Peckham
Journal:  Cancer       Date:  1982-12-01       Impact factor: 6.860

9.  Molecular heterogeneity of human chorionic gonadotropin and its subunits in testicular cancer.

Authors:  K Mann; H J Karl
Journal:  Cancer       Date:  1983-08-15       Impact factor: 6.860

10.  Tumour markers in testicular germ cell tumours. Five-year experience from the DATECA Study 1976-1980.

Authors:  B Nørgaard-Pedersen; H P Schultz; J Arends; H Brincker; G Krag Jacobsen; B Lindeløv; M Rørth; I L Svennekjaer
Journal:  Acta Radiol Oncol       Date:  1984
View more
  2 in total

1.  An assessment of combined tumour markers in patients with seminoma: placental alkaline phosphatase (PLAP), lactate dehydrogenase (LD) and beta human chorionic gonadotrophin (beta HCG).

Authors:  A J Munro; O S Nielsen; W Duncan; J Sturgeon; M K Gospodarowicz; A Malkin; G M Thomas; M A Jewett
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

2.  Serum Tumour Markers in Testicular Germ Cell Tumours: Frequencies of Elevated Levels and Extents of Marker Elevation Are Significantly Associated with Clinical Parameters and with Response to Treatment.

Authors:  Klaus-Peter Dieckmann; Hanna Simonsen-Richter; Magdalena Kulejewski; Petra Anheuser; Henrik Zecha; Hendrik Isbarn; Uwe Pichlmeier
Journal:  Biomed Res Int       Date:  2019-05-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.